(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid

CAS : 53101-49-8

Ref. 3D-DCA10149

Informations sur le produit

• Nom: (R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
• Synonymes: (2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylic acid

Description

(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (HMCA) is a supplement that is used to treat cancer. HMCA is an acetyl donor and can be used as a substitute for erythromycin. HMCA was shown to inhibit the growth of human breast cancer cells in culture by reacting with lorazepam and lipase to form a reactive intermediate. This compound has been immobilized on ion-exchange resin for use in biodegradable materials and can be used for the treatment of chronic obstructive pulmonary disease (COPD).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 250.29 g/mol
• Formule: C₁₄H₁₈O₄
• Degré de pureté: Min. 95%